An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

The HPV vaccine offers protection against the most common high-risk HPV strains (16 and 18) as well as others that can cause ...

According to Dr. Sanjay Wazir, an expert at the Motherhood Hospital Gurgaon, "The HPV vaccine is crucial for boys and men for ...

Cervical cancer, the fourth most common cancer among women globally, remains a critical yet often overlooked <a target=_blank href= ...

The connection between oral sex and cancer has become a topic of growing concern in recent years. This relationship centers ...

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.

The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

Of note, many patients remained in the cohort and were untested through this first round of surveillance (overall: 49.4%; ...